1,3,4,6-四(丁氧基甲基)甘脲，CAS 登记号 15968-37-3，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1,3,4,6-四(丁氧基甲基)甘脲 的 CAS 号：15968-37-3，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1,3,4,6-tetrakis(butoxymethyl)glycoluril · CAS 15968-37-3 · C24H46N4O6. UNII C24H46N4O6.
| CAS Registry Number | 15968-37-3 |
|---|---|
| PubChem CID | 85216 |
| Molecular formula | C24H46N4O6 |
| IUPAC name | 1,3,4,6-tetrakis(butoxymethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione |
| UNII (FDA) | C24H46N4O6 |
| Molecular Weight | 486.6 |
|---|---|
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 20 |
| Exact Mass | 486.34173520 |
| Monoisotopic Mass | 486.34173520 |
| Topological Polar Surface Area | 84 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Reported hazard statements | H350 (100%) |
|---|
H350 (100%): May cause cancer [Danger Carcinogenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
15968-37-3; 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione; 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo(4,5-d)imidazole-2,5(1H,3H)-dione; EINECS 240-108-7; DTXSID70166708; Imidazo(4,5-d)imidazole-2,5(1H,3H)-dione, 1,3,4,6-tetrakis(butoxymethyl)tetrahydro-; RefChem:72241; DTXCID0089199; 240-108-7; 1,3,4,6-TETRAKIS(BUTOXYMETHYL)GLYCOLURIL, TECH.; 1,3,4,6-tetrakis(butoxymethyl)-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione; MFCD00216661; UUOUGRUMSRMJHY-UHFFFAOYSA-N; C24H46N4O6; SCHEMBL124787; SY446177
CAS 15968-37-3; molecular formula C24H46N4O6; molecular weight — g/mol.
15968-37-3, 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione, 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo(4,5-d)imidazole-2,5(1H,3H)-dione, EINECS 240-108-7, DTXSID70166708, Imidazo(4,5-d)imidazole-2,5(1H,3H)-dione, 1,3,4,6-tetrakis(butoxymethyl)tetrahydro-.
Hazard statements reported: H350.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.